HRP940271B1 - Intermediate for azithromycin - Google Patents

Intermediate for azithromycin

Info

Publication number
HRP940271B1
HRP940271B1 HR08/064,610A HRP940271A HRP940271B1 HR P940271 B1 HRP940271 B1 HR P940271B1 HR P940271 A HRP940271 A HR P940271A HR P940271 B1 HRP940271 B1 HR P940271B1
Authority
HR
Croatia
Prior art keywords
pct
date nov
sec
iii
compound
Prior art date
Application number
HR08/064,610A
Other languages
English (en)
Inventor
V Yang Bingwei
Original Assignee
Pfizer
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer filed Critical Pfizer
Publication of HRP940271A2 publication Critical patent/HRP940271A2/xx
Publication of HRP940271B1 publication Critical patent/HRP940271B1/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H17/00—Compounds containing heterocyclic radicals directly attached to hetero atoms of saccharide radicals
    • C07H17/04—Heterocyclic radicals containing only oxygen as ring hetero atoms
    • C07H17/08—Hetero rings containing eight or more ring members, e.g. erythromycins
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H17/00—Compounds containing heterocyclic radicals directly attached to hetero atoms of saccharide radicals
HR08/064,610A 1993-05-19 1994-04-27 Intermediate for azithromycin HRP940271B1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US6461093A 1993-05-19 1993-05-19

Publications (2)

Publication Number Publication Date
HRP940271A2 HRP940271A2 (en) 1996-12-31
HRP940271B1 true HRP940271B1 (en) 2000-02-29

Family

ID=22057118

Family Applications (1)

Application Number Title Priority Date Filing Date
HR08/064,610A HRP940271B1 (en) 1993-05-19 1994-04-27 Intermediate for azithromycin

Country Status (12)

Country Link
US (1) US5686587A (xx)
EP (1) EP0699207B1 (xx)
JP (1) JP2696608B2 (xx)
AT (1) ATE154806T1 (xx)
CA (1) CA2162401C (xx)
DE (1) DE69403963T2 (xx)
DK (1) DK0699207T3 (xx)
ES (1) ES2104386T3 (xx)
FI (1) FI110781B (xx)
GR (1) GR3024297T3 (xx)
HR (1) HRP940271B1 (xx)
WO (1) WO1994026758A1 (xx)

Families Citing this family (26)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
HRP20020231A2 (en) 2002-03-18 2003-12-31 Pliva D D ISOSTRUCTURAL PSEUDOPOLYMORPHS OF 9-DEOXO-9a-AZA-9a-METHYL-9a-HOMOERYTHROMYCIN A
ES2122905B1 (es) * 1996-07-11 1999-11-16 Astur Pharma Sa Sintesis de 11,12-hidrogenoortoborato de 9-desoxo-9a-aza-11,12-desoxi-9a-metil-9a-homoeritromicina a. un procedimiento para la preparacion de 9-desoxo-9a-aza-9a-metil-9a-homoeritromicina a dihidrato (azitromicina dihidrato).
GB9705323D0 (en) * 1997-03-14 1997-04-30 Biochemie Sa Organic compounds
PT102006B (pt) * 1997-05-19 2000-06-30 Hovione Sociedade Quimica S A Novo processo de preparacao de azitromicina
HRP980189B1 (en) * 1998-04-06 2004-04-30 Pliva Pharm & Chem Works Novel 15-membered lactams ketolides
GB9824580D0 (en) * 1998-11-10 1999-01-06 Biochemie Sa Organic compounds
EP1206476B1 (en) * 1999-08-24 2006-01-04 Abbott Laboratories 9a-azalides with antibacterial activity
US6764996B1 (en) 1999-08-24 2004-07-20 Abbott Laboratories 9a-azalides with antibacterial activity
ES2177373B1 (es) * 1999-11-26 2003-11-01 Astur Pharma Sa Preparacion de azitromicina en su forma no cristalina
US6528492B1 (en) 2000-07-25 2003-03-04 Instituto De Investigacion En Quimica Aplicada S.C. Single-step process for preparing 7, 16-deoxy-2-aza-10-0-cladinosil-12-0-desosaminil-4, 5-dihydroxy-6-ethyl-3,5,9,11,13,15-hexamethylbicycle (11.2.1) hexadeca-1(2)-en-ona and obtaining a new form of 9-deoxo-9a-methyl-9a-aza-9a-homoerythromycin a
CA2419873A1 (en) 2000-08-23 2002-02-28 Wockhardt Limited Process for preparation of anhydrous azithromycin
ES2179756B1 (es) * 2000-11-30 2004-10-01 Ercros Industrial, S.A. Procedimiento de obtencion de azaeritromicina.
EP1671978A1 (en) 2001-05-22 2006-06-21 Pfizer Products Inc. New Cristal Form of Azithromycin
YU8804A (sh) * 2001-08-21 2006-08-17 Pfizer Products Inc. Jedno-dozni azitromicin
HRP20020614A2 (en) 2002-07-22 2004-06-30 PLIVA-ISTRAŽIVAČKI INSTITUT d.o.o. Rhombic pseudopolymorph of 9-deoxo-9a-aza-9a-methyl-9a-homoerythromycin a
US6645941B1 (en) * 2003-03-26 2003-11-11 Enanta Pharmaceuticals, Inc. 6,11-3C-bicyclic 9a-azalide derivatives
US7276487B2 (en) * 2003-09-23 2007-10-02 Enanta Pharmaceuticals, Inc. 9a, 11-3C-bicyclic 9a-azalide derivatives
WO2005070113A2 (en) * 2004-01-09 2005-08-04 Enanta Pharmaceuticals, Inc. 9n-substituted 6-11 bicyclic erythromycin derivatives
US7468428B2 (en) 2004-03-17 2008-12-23 App Pharmaceuticals, Llc Lyophilized azithromycin formulation
WO2006011160A1 (en) 2004-06-28 2006-02-02 Alembic Limited Process for the preparation of azithromycin monohydrate isopropanol clathrate
US7384922B2 (en) * 2005-05-04 2008-06-10 Enanta Pharmaceuticals, Inc. 6-11 bridged oxime erythromycin derivatives
WO2007015265A2 (en) * 2005-05-24 2007-02-08 Kopran Research Laboratories Ltd A process for preparing 6,9-imino ether
US7407942B2 (en) * 2006-03-29 2008-08-05 Emata Pharmaceuticals, Inc 3,6-bridged 9,12-oxolides
CN102863486A (zh) * 2012-09-18 2013-01-09 太仓市运通化工厂 一种9-脱氧-9a-氮杂-9a-高红霉素的合成方法
CN104262429A (zh) * 2014-10-03 2015-01-07 菏泽市方明制药有限公司 一种阿奇霉素的纯化方法
CN108530494B (zh) * 2018-06-29 2021-03-30 宜昌东阳光生化制药有限公司 一种阿奇霉素重排杂质r的合成方法

Family Cites Families (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SI7910768A8 (en) * 1979-04-02 1996-06-30 Pliva Pharm & Chem Works Process for pripering 11-aza-4-0-cladinosyl-6-0-desosaminyl-15-ethyl- 7,13,14-trihydroxy-3,5,7,9,12,14-hexamethyl- oxacyclopentadecane-2-one and their derivatives
YU43006B (en) * 1981-03-06 1989-02-28 Pliva Pharm & Chem Works Process for preparing n-methyl-11-aza-10-deoxo-10-dihydro erythromycin and derivatives thereof
US4382085A (en) * 1982-03-01 1983-05-03 Pfizer Inc. 4"-Epi erythromycin A and derivatives thereof as useful antibacterial agents
US4474768A (en) * 1982-07-19 1984-10-02 Pfizer Inc. N-Methyl 11-aza-10-deoxo-10-dihydro-erytromycin A, intermediates therefor
US4526889A (en) * 1982-11-15 1985-07-02 Pfizer Inc. Epimeric azahomoerythromycin A derivative, intermediates and method of use
US4464527A (en) * 1983-06-30 1984-08-07 Pfizer Inc. Antibacterial 9-deoxo-9a-alkyl-9a-aza-9a-homoerythromycin A derivatives and intermediates therefore
YU43658B (en) * 1983-07-18 1989-10-31 Pliva Pharm & Chem Works Process for preparing 7,16-dioxa-2-aza-10-0-cladinosyl-12,0-desosaminyl-4,5-dihydroxy-6-ethyl-3,5,9,11,13,15-hexamethyl-bicyclo(11.2.1)hexadeca-1(2)-ene-8
US4518590A (en) * 1984-04-13 1985-05-21 Pfizer Inc. 9α-Aza-9α-homoerythromycin compounds, pharmaceutical compositions and therapeutic method
US4512982A (en) * 1984-04-13 1985-04-23 Pfizer Inc. 9α-Aza-9α-homoerythromycin compounds, pharmaceutical composition and therapeutic method
EP0503932B1 (en) * 1991-03-15 1998-12-02 Merck & Co. Inc. 9-Deoxo-9(z)-hydroxy-iminoerythromycin A and O-derivatives thereof
US5912331A (en) * 1991-03-15 1999-06-15 Merck & Co., Inc. Process for the preparation of 9-deoxo-9(Z)-hydroxyiminoerythromycin A
CA2064634C (en) * 1991-04-04 1998-08-04 James V. Heck 9-deoxo-8a-aza-8a-homoerythromycin a derivatives modified at the 4"- and8a-positions
US5202434A (en) * 1991-04-05 1993-04-13 Merck & Co., Inc. 8a-aza-8a-homoerythromycin lactams
CA2065222A1 (en) * 1991-04-09 1992-10-10 Robert R. Wilkening Process for the preparation of 8a-aza-8a-homoerythromycin cyclic iminoethers
EP0508795A1 (en) * 1991-04-10 1992-10-14 Merck & Co. Inc. 8a-aza-8a-homoerythromycin cyclic iminoethers
US5189159A (en) * 1992-04-02 1993-02-23 Merck & Co., Inc. 8a-AZA-8a-homoerythromycin cyclic iminoethers
CA2065218A1 (en) * 1991-04-11 1992-10-12 Robert R. Wilkening Process for the preparation of 9-deoxo-8a-aza-8a-homoerythromycin a and its 8a-alkyl derivatives

Also Published As

Publication number Publication date
WO1994026758A1 (en) 1994-11-24
JPH08506596A (ja) 1996-07-16
CA2162401A1 (en) 1994-11-24
GR3024297T3 (en) 1997-10-31
FI942313A0 (fi) 1994-05-18
FI942313A (fi) 1994-11-20
EP0699207B1 (en) 1997-06-25
CA2162401C (en) 1998-11-03
EP0699207A1 (en) 1996-03-06
HRP940271A2 (en) 1996-12-31
ATE154806T1 (de) 1997-07-15
DE69403963T2 (de) 1997-11-20
US5686587A (en) 1997-11-11
DE69403963D1 (de) 1997-07-31
ES2104386T3 (es) 1997-10-01
DK0699207T3 (da) 1997-12-08
JP2696608B2 (ja) 1998-01-14
FI110781B (fi) 2003-03-31

Similar Documents

Publication Publication Date Title
HRP940271B1 (en) Intermediate for azithromycin
GB2270075B (en) Substituted 2-phenyl-3-methoxypropenoate fungicides
AU2534295A (en) Gastrin and cck antagonists
TW263499B (xx)
SG47046A1 (en) Risperidone pamoate
PT687260E (pt) Processo para a preparacao de 9-desoxotaxanos
HU9603289D0 (en) The preparation of nalbuphine having low levels of beta-epimer
DE69428546D1 (en) 3-acylaminobenzazepine
ZA961364B (en) 1-Aryl-2-acylamino-ethane compounds
AU6991696A (en) 3-beta-aminoazabicyclo-octane or -nonane naphthamide derivatives as antipsychotic agents
GB9410207D0 (en) Process
TW344650B (en) Fungicidal compositions and the process for the preparation thereof
GB9318790D0 (en) Heterocyclic derivatives
AU2307595A (en) A process for the preparation of 5,6-dihydroxy-2-amino- 1,2,3,4-tetrahydronaphthalene derivatives
TW239124B (en) Process for the preparation of 2,4,5-tribromopyrrole-3-carbonitrile
ZA954053B (en) Intermediate for preparing a pharmaceutically active compound
IL126548A0 (en) Use of aspirochlorine or derivatives thereof as immunosuppressive agents
MX9605415A (es) Derivado de propiofenona y procedimientos para preparar el mismo.

Legal Events

Date Code Title Description
A1OB Publication of a patent application
AIPI Request for the grant of a patent on the basis of a substantive examination of a patent application
B1PR Patent granted
ODRP Renewal fee for the maintenance of a patent

Payment date: 20040102

Year of fee payment: 11

PBON Lapse due to non-payment of renewal fee

Effective date: 20050428